JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.5% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
PUT
Johnson & Johnson
JNJ
$629B
| $34.7M | ﹤0.01% |
195,300
-31,900
| -14% | -$5.68M |
|
1227
Cameco
CCJ
$43.1B
| $34.6M | ﹤0.01% |
1,646,858
+43,796
| +3% | +$1.1M |
|
1228
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
| $34.6M | ﹤0.01% |
83,561
-25,354
| -23% | -$11.4M |
|
|
BKI
1229
DELISTED
Black Knight, Inc. Common Stock
BKI
| $34.5M | ﹤0.01% |
528,304
+7,952
| +2% | +$535K |
|
1230
PUT
Intel
INTC
$509B
| $34.4M | ﹤0.01% |
919,400
-537,200
| -37% | -$23.2M |
|
1231
CareTrust REIT
CTRE
$9.26B
| $34.4M | ﹤0.01% |
1,863,649
-61,267
| -3% | -$1.09M |
|
|
MDRX
1232
DELISTED
Veradigm Inc. Common Stock
MDRX
| $34.3M | ﹤0.01% |
2,315,274
-456,501
| -16% | -$8.54M |
|
1233
TransDigm Group
TDG
$68.3B
| $34.3M | ﹤0.01% |
63,840
-50,794
| -44% | -$30M |
|
1234
Golub Capital BDC
GBDC
$3.4B
| $34.3M | ﹤0.01% |
2,643,471
+308,826
| +13% | +$4.42M |
|
1235
CVB Financial
CVBF
$4.05B
| $34.2M | ﹤0.01% |
1,380,031
+789,687
| +134% | +$18.9M |
|
1236
PUT
Alphabet (Google) Class A
GOOGL
$4.2T
| $34.2M | ﹤0.01% |
314,000
-156,000
| -33% | -$18.4M |
|
1237
nLIGHT
LASR
$3.06B
| $34.1M | ﹤0.01% |
3,334,631
+6,971
| +0.2% | +$90K |
|
1238
John Wiley & Sons Class A
WLY
$2.54B
| $34.1M | ﹤0.01% |
713,487
-52,892
| -7% | -$2.7M |
|
1239
CALL
Wells Fargo
WFC
$269B
| $34.1M | ﹤0.01% |
869,900
-1,189,900
| -58% | -$52.2M |
|
1240
PUT
Procter & Gamble
PG
$335B
| $33.9M | ﹤0.01% |
235,900
+47,400
| +25% | +$7.12M |
|
1241
Chemours
CC
$2.29B
| $33.9M | ﹤0.01% |
1,058,760
+492,475
| +87% | +$18.1M |
|
|
WLL
1242
DELISTED
Whiting Petroleum Corporation
WLL
| $33.9M | ﹤0.01% |
497,646
-140,903
| -22% | -$11.4M |
|
1243
Charles River Laboratories
CRL
$13.6B
| $33.8M | ﹤0.01% |
157,971
-97,487
| -38% | -$23.8M |
|
1244
CALL
S&P Global
SPGI
$121B
| $33.7M | ﹤0.01% |
+100,000
| New | +$35.6M |
|
1245
Clearway Energy Class C
CWEN
$7.06B
| $33.6M | ﹤0.01% |
965,205
-18,463
| -2% | -$622K |
|
1246
Tyler Technologies
TYL
$13B
| $33.6M | ﹤0.01% |
101,111
+17,645
| +21% | +$6.46M |
|
1247
Idacorp
IDA
$8.21B
| $33.6M | ﹤0.01% |
317,352
+14,437
| +5% | +$1.56M |
|
1248
Qorvo
QRVO
$8.67B
| $33.4M | ﹤0.01% |
353,948
-2,692
| -0.8% | -$290K |
|
1249
Intellia Therapeutics
NTLA
$1.7B
| $33.3M | ﹤0.01% |
642,464
+14,495
| +2% | +$736K |
|
1250
HUB Group
HUBG
$2.46B
| $33.2M | ﹤0.01% |
935,720
-38,522
| -4% | -$1.35M |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.